跳至主要内容
临床试验/NCT03987776
NCT03987776已完成不适用

The Effect of an Anti-Inflammatory Diet on Weight Loss, Body Composition, Cardiometabolic Risk Factors and Immune System Response in Younger Adults

Clinical Hospital Center Rijeka2 个研究点 分布在 1 个国家目标入组 220 人开始时间: 2019年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
220
试验地点
2
主要终点
The changes in the body mass index

研究概览

简要总结

Diet has a major role in the etiology of obesity, and there is a growing body of evidence suggesting that a variety of dietary factors can modulate obesity-induced chronic low-grade inflammation and thus the course of obesity-related chronic non-communicable diseases. The present intervention study aims to evaluate the effect of an anti-inflammatory diet on weight loss, body composition, cardiometabolic risk factors and immune system response among young adults of the obese younger adults.

详细描述

Obesity pandemic presents a major challenge to chronic disease prevention worldwide. A low-grade chronic inflammation is associated with obesity and related cardiometabolic disorders, such as cardiovascular diseases, type 2 diabetes and some type of cancers. Diet has a major role in the etiology of obesity, and there is a growing body of evidence suggesting that a variety of dietary factors can modulate obesity-induced chronic low-grade inflammation and thus the course of obesity-related chronic non-communicable diseases. The present intervention study aims to evaluate the effect of an anti-Inflammatory diet on weight loss, body composition, cardiometabolic risk factors and immune system response among younger adults. A nutritional intervention based on an energy-restricted anti-inflammatory diet will be compared with an isocaloric standard diet (55-60% carbohydrates, 25% fat, 15-20% protein). The inflammatory potential of the diet will be assessed with the Dietary Inflammatory Index®.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • adults age of 18 to 50 years
  • body mass index ≥ 30 kg/m2
  • with or without obesity related complications

排除标准

  • chronic hearth, renal and/or liver diseases,
  • active carcinoma or having carcinoma in last year
  • anti-inflammatory and/or immunosuppressive drugs intake
  • changing the existing medication therapy
  • persons older than 50 years
  • active infection and/or surgical procedure in last 3 months
  • nutritive allergy or intolerance to any anti-inflammatory diet constituent
  • pregnancy

结局指标

主要结局

The changes in the body mass index

时间窗: baseline, follow up 6 months

body mass index (kg/m2) calculated from measured body weight (kg) and height (m)

The changes of fat mass

时间窗: baseline, follow up 6 months

fat mass (kg) measured with bioelectric impedance analyzer

The changes in the waist circumference

时间窗: baseline, follow up 6 months

waist circumference (cm) measured with measuring tape

The changes of visceral adipose tissue

时间窗: baseline, follow up 6 months

visceral adipose tissue (l) measured with bioelectric impedance analyzer

The changes of skeletal muscle mass

时间窗: baseline, follow up 6 months

skeletal muscle mass (kg) measured with bioelectric impedance analyzer

The changes of fat-free mass

时间窗: baseline, follow up 6 months

fat-free mass (kg) measured with bioelectric impedance analyzer

次要结局

  • The changes in free tri-iodothyronine (fT3) concentration(baseline, follow up 6 months)
  • The changes in serum lipid profile(baseline, follow up 6 months)
  • The changes in serum liver transaminases concentration(baseline, follow up 6 months)
  • The changes in insulin concentration(baseline, follow up 6 months)
  • The changes of HOMA-index(baseline, follow up 6 months)
  • The changes in fasting glucose concentration(baseline, follow up 6 months)
  • The changes in HbA1c concentration(baseline, follow up 6 months)
  • The changes in serum IL-beta, IL-6 and TNF-alpha concentrations(baseline, follow up 6 months)
  • The changes in serum hs-C-reactive protein concentration(baseline, follow up 6 months)
  • The changes of blood lymphocytes T and lymphocite subgroups count(baseline, follow up 6 months)
  • The changes in thyroid stimulating hormone (TSH) concentration(baseline, follow up 6 months)
  • The changes in free thyroxine (fT4) concentration(baseline, follow up 6 months)
  • The changes in thyroid peroxidase antibodies (TPOAbs) concentration(baseline, follow up 6 months)

研究者

发起方
Clinical Hospital Center Rijeka
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sanja Klobučar Majanović

Assistant Professor

Clinical Hospital Center Rijeka

研究点 (2)

Loading locations...

相似试验